NCT04280549View on ClinicalTrials.gov

Platelet PAR-1 Activation in Health and Diabetes

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

February 2, 2021

Study Completion Date

February 2, 2021

Conditions
Type 2 DiabetesHealthy
Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT04280549 - Platelet PAR-1 Activation in Health and Diabetes | Biotech Hunter | Biotech Hunter